Monday, December 23

Tag: Vaccines

Flu and COVID-19 infections rise ahead of holiday gatherings
23Dec By adminNo Comments
Health

Flu and COVID-19 infections rise ahead of holiday gatherings

Flu and COVID-19 infections rise ahead of holiday gatherings - CBS News Watch CBS News An increase in COVID-19 and flu infection rates could get worse in coming weeks, fueled by holiday gatherings and low vaccination rates. CBS News' Lilia Luciano shares what you can do to keep yourself and your loved ones safe. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On
Read More
The Covid Vaccine Windfall Turns for Pfizer and Moderna
19Nov By adminNo Comments
World

The Covid Vaccine Windfall Turns for Pfizer and Moderna

Updated Nov. 19, 2023 3:03 pm ETThe U.S. was in a fit of Covid panic during Thanksgiving week two years ago. The Omicron variant had emerged like a creature from the Black Lagoon. Public-health officials indicated we’d need another updated booster. Share prices in Pfizer and Moderna surged. By month’s end, Pfizer’s stock-market value had surpassed $300 billion, up 50% from the start of the pandemic. Moderna’s shares had soared by more than 1,000% over the same period. In 2022 Pfizer became the first pharmaceutical company to book more than $100 billion in annual sales owing to government purchases of its vaccines and antiviral pill.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
School vaccination exemptions now highest on record among kindergartners, CDC reports
11Nov By adminNo Comments
Health

School vaccination exemptions now highest on record among kindergartners, CDC reports

Measles, chickenpox cases on the rise Vaccine hesitancy sparks measles, chickenpox rise 04:58 A record number of American kindergarten students started school last year with an exemption from one of the key vaccines health authorities require, according to new data from the Centers for Disease Control and Prevention.In the report published Thursday, the CDC examined immunization program data to assess vaccination coverage and exemption statu...
Read More
GSK PLC Raises Guidance After RSV Vaccine Lifts Earnings
1Nov By adminNo Comments
World

GSK PLC Raises Guidance After RSV Vaccine Lifts Earnings

Updated Nov. 1, 2023 4:08 am ETGSK PLC raised its guidance after third-quarter net profit rose mainly due to the U.S. launch of its Arexvy vaccine, although it missed analysts’ forecasts.The British pharmaceutical giant said Wednesday that net profit from continuing operations for the third quarter was 1.46 billion pounds ($1.77 billion), boosted by the vaccine for respiratory syncytial virus, or RSV, compared with GBP759 million a year earlier and a company-compiled consensus of GBP1.87 billion.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Katalin Karikó’s Nobel Prize Marks the Beginning of a Vaccine Revolution
2Oct By adminNo Comments
Technology

Katalin Karikó’s Nobel Prize Marks the Beginning of a Vaccine Revolution

No one expected the first Covid-19 vaccine to be as good as it was. “We were hoping for around 70 percent, that’s a success,” says Dr Ann Falsey, a professor of medicine at the University of Rochester, New York, who ran a 150-person trial site for the Pfizer-BioNTech vaccine in 2020.Even Uğur Şahin, the co-founder and CEO of BioNTech, who had shepherded the drug from its earliest stages, had some doubts. All the preliminary laboratory tests looked good; having seen them, he would routinely tell people that “immunologically, this is a near-perfect vaccine.” But that doesn’t always mean it will work against “the beast, the thing out there” in the real world. It wasn’t until November 9, 2020, three months into the final clinical trial, that he finally got the good news. “More than 90 percent...
Read More